Cargando…
Corrigendum to “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada”
Autores principales: | Thanh, Nguyen Xuan, Jacobs, Philip, Suggett, Jason, McIvor, Andrew, Kaplan, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545761/ https://www.ncbi.nlm.nih.gov/pubmed/31236147 http://dx.doi.org/10.1155/2019/5906984 |
Ejemplares similares
-
Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada
por: Thanh, Nguyen Xuan, et al.
Publicado: (2019) -
Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations
por: Khoudigian-Sinani, Shoghag, et al.
Publicado: (2017) -
Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika(®) and Acapella(®) Devices
por: Tse, Jenny, et al.
Publicado: (2020) -
A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care Upon Healthcare Resource Utilization and Costs in Post-Operative Patients
por: Burudpakdee, Chakkarin, et al.
Publicado: (2018) -
Impact of Aerobika(®) oscillating positive expiratory pressure in improving small airway resistance, lung function, symptoms and exercise capacity in chronic obstructive pulmonary disease
por: Sahardin, Siti Nurhanis, et al.
Publicado: (2023)